tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Scynexis announces results from Phase 1 SAD/MAD study of SCY-247
PremiumThe FlyScynexis announces results from Phase 1 SAD/MAD study of SCY-247
1M ago
Promising Potential of SCY-247: A Game-Changer in Antifungal Treatment
Premium
Ratings
Promising Potential of SCY-247: A Game-Changer in Antifungal Treatment
2M ago
Scynexis announces presentations highlighting data on SCY-247
Premium
The Fly
Scynexis announces presentations highlighting data on SCY-247
2M ago
SCYNEXIS Inc. Advances Antifungal Treatment with Phase 3 Study
PremiumCompany AnnouncementsSCYNEXIS Inc. Advances Antifungal Treatment with Phase 3 Study
3M ago
SCYNEXIS Holds Annual Meeting, Re-elects Directors
Premium
Company Announcements
SCYNEXIS Holds Annual Meeting, Re-elects Directors
4M ago
SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price
Premium
Company Announcements
SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price
4M ago
Scynexis reports Q1 EPS (11c), consensus (19c)
PremiumThe FlyScynexis reports Q1 EPS (11c), consensus (19c)
6M ago
Scynexis expects cash to fund operations into Q3 of 2026
Premium
The Fly
Scynexis expects cash to fund operations into Q3 of 2026
6M ago
SCYX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SCYX Earnings this Week: How Will it Perform?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100